| scholarly article | Q13442814 |
| P50 | author | Wayne C. Drevets | Q36469219 |
| Mark Hallett | Q42410679 | ||
| P2093 | author name string | Dennis L Murphy | |
| Diane Kazuba | |||
| Zoltan Mari | |||
| Janine M Simmons | |||
| Richard E Carson | |||
| Omer Bonne | |||
| Peter Herscovitch | |||
| Anto Bagic | |||
| Alicja Lerner | |||
| Ben Xu | |||
| P2860 | cites work | Orbital Frontal and Amygdala Volume Reductions in Obsessive-compulsive Disorder | Q22253044 |
| Disorders of the Cerebellum: Ataxia, Dysmetria of Thought, and the Cerebellar Cognitive Affective Syndrome | Q22306268 | ||
| How do you feel? Interoception: the sense of the physiological condition of the body | Q28216765 | ||
| International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function | Q28275171 | ||
| Cell migration from the ganglionic eminences is required for the development of hippocampal GABAergic interneurons | Q28507169 | ||
| Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex | Q29391304 | ||
| Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing | Q30474917 | ||
| Sexually dimorphic expression of KCC2 and GABA function | Q30487718 | ||
| PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome | Q33732591 | ||
| Differential origins of neocortical projection and local circuit neurons: role of Dlx genes in neocortical interneuronogenesis | Q33739097 | ||
| Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome | Q33758561 | ||
| Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome | Q33947856 | ||
| A volumetric MRI study of Gilles de la Tourette's syndrome | Q34065051 | ||
| Subunit composition, distribution and function of GABA(A) receptor subtypes | Q34143787 | ||
| Dopaminergic dysfunction in tourette syndrome | Q34249660 | ||
| Putting a spin on the dorsal-ventral divide of the striatum. | Q34335471 | ||
| The role of the amygdala in fear and anxiety | Q34401070 | ||
| Forebrain emotional asymmetry: a neuroanatomical basis? | Q34465915 | ||
| Three-dimensional MRI atlas of the human cerebellum in proportional stereotaxic space | Q34504743 | ||
| The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity | Q34541374 | ||
| Biogenic amine metabolism in tourette syndrome | Q34561868 | ||
| Nonlinear spatial normalization using basis functions | Q48160511 | ||
| Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo | Q48238969 | ||
| Basal Ganglia volumes in patients with Gilles de la Tourette syndrome | Q48335400 | ||
| Altered mesolimbocortical and thalamic dopamine in Tourette syndrome | Q48371151 | ||
| Abnormal cerebral activation associated with a motor task in Tourette syndrome. | Q48380337 | ||
| Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging | Q48431253 | ||
| A functional magnetic resonance imaging study of tic suppression in Tourette syndrome | Q48485554 | ||
| Functional neuroanatomy of Tourette syndrome. Limbic-motor interactions studied with FDG PET | Q48585891 | ||
| Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study. | Q48625891 | ||
| Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation | Q48631034 | ||
| D2-like dopamine receptor density in Tourette syndrome measured by PET. | Q48651659 | ||
| Increased midbrain gray matter in Tourette's syndrome | Q48672448 | ||
| The cerebellum communicates with the basal ganglia | Q48744096 | ||
| Spatial transformation during 3D reconstruction in positron emission tomography. | Q52248887 | ||
| Prospective randomized double-blind trial of bilateral thalamic deep brain stimulation in adults with Tourette syndrome. | Q53170957 | ||
| Nonlinear spatial normalization using basis functions | Q53178416 | ||
| Crossed cerebro-cerebellar language dominance | Q60686021 | ||
| Visual–motor integration functioning in children with Tourette syndrome | Q61793764 | ||
| Possible exacerbation of tics by androgenic steroids | Q68791267 | ||
| Distribution of central omega 1 (benzodiazepine1) and omega 2 (benzodiazepine2) receptor subtypes in the monkey and human brain. An autoradiographic study with [3H]flunitrazepam and the omega 1 selective ligand [3H]zolpidem | Q69839123 | ||
| Accurate attenuation correction despite movement during PET imaging | Q72116802 | ||
| The functional neuroanatomy of Tourette's syndrome: an FDG-PET study. I. Regional changes in cerebral glucose metabolism differentiating patients and controls | Q72766338 | ||
| Dopamine D2 receptor imaging in Gilles de la Tourette syndrome | Q73518581 | ||
| Altered interhemispheric connectivity in individuals with Tourette's disorder | Q80930838 | ||
| Hippocampus and amygdalar volumes in patients with refractory obsessive-compulsive disorder | Q81292799 | ||
| Abnormal thalamic volume in treatment-naïve boys with Tourette syndrome | Q82156762 | ||
| GABAergic signaling in the developing cerebellum | Q82706814 | ||
| Internal pallidal and thalamic stimulation in patients with Tourette syndrome | Q34594215 | ||
| Development of cortical GABAergic circuits and its implications for neurodevelopmental disorders | Q34642137 | ||
| Cerebellar morphology in Tourette syndrome and obsessive-compulsive disorder | Q34855756 | ||
| Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette's syndrome | Q35183257 | ||
| Positron emission tomography evaluation of dopamine D-2 receptors in adults with Tourette syndrome | Q35438512 | ||
| The biology of epilepsy genes | Q35550542 | ||
| Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome. Report of three cases | Q35620595 | ||
| Morphologic features of the amygdala and hippocampus in children and adults with Tourette syndrome | Q36536119 | ||
| Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder | Q36632016 | ||
| GABAA receptor heterogeneity, function, and implications for epilepsy | Q36740096 | ||
| Functional MRI and the study of OCD: from symptom provocation to cognitive-behavioral probes of cortico-striatal systems and the amygdala | Q36888006 | ||
| Development of GABA innervation in the cerebral and cerebellar cortices. | Q36912760 | ||
| Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. | Q36966673 | ||
| Involvement of insula and cingulate cortices in control and suppression of natural urges | Q37089866 | ||
| Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects | Q37369444 | ||
| A functional neuroanatomy of tics in Tourette syndrome | Q39171985 | ||
| Neuroanatomy of Gilles de la Tourette's Syndrome Possible Midbrain Involvement | Q40152993 | ||
| High presynaptic dopaminergic activity in children with Tourette's disorder | Q40828297 | ||
| Striatal interneurones: chemical, physiological and morphological characterization | Q40991491 | ||
| Tourette's syndrome: a disorder of cingulate and orbitofrontal function? | Q41075833 | ||
| Benzodiazepine receptor sites in the human brain: autoradiographic mapping. | Q41277714 | ||
| Origin and molecular specification of striatal interneurons. | Q41753651 | ||
| Inhibitory deficits in Tourette's syndrome | Q41854444 | ||
| Expression of 10 GABA(A) receptor subunit messenger RNAs in the motor-related thalamic nuclei and basal ganglia of Macaca mulatta studied with in situ hybridization histochemistry | Q42455967 | ||
| Sexual dimorphism and developmental regulation of substantia nigra function | Q43798247 | ||
| Evaluation of the reference tissue models for PET and SPECT benzodiazepine binding parameters | Q44177602 | ||
| Increased ventral striatal monoaminergic innervation in Tourette syndrome | Q44545765 | ||
| Gilles de la Tourette's syndrome. A postmortem neuropathological and immunohistochemical study | Q44760357 | ||
| Neural correlates of tic severity and cognitive control in children with Tourette syndrome | Q44857193 | ||
| Thalamic deep brain stimulation for treatment-refractory Tourette syndrome: two-year outcome. | Q44978602 | ||
| Differentiating attention-deficit/hyperactivity disorder inattentive and combined types: a (1)H-magnetic resonance spectroscopy study of fronto-striato-thalamic regions. | Q46034079 | ||
| [18F]flumazenil binding to central benzodiazepine receptor studies by PET--quantitative analysis and comparisons with [11C]flumazenil | Q46167996 | ||
| Excitability of motor cortex inhibitory circuits in Tourette syndrome before and after single dose nicotine | Q46387157 | ||
| The functional neuroanatomy of coordinated orofacial movements: sparse sampling fMRI of whistling | Q47751635 | ||
| Intracortical hyperexcitability in humans with a GABAA receptor mutation | Q48113383 | ||
| Neuroimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome | Q48147103 | ||
| P433 | issue | Pt 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Tourette syndrome | Q191779 |
| P304 | page(s) | 1926-1936 | |
| P577 | publication date | 2012-05-10 | |
| P1433 | published in | Brain | Q897386 |
| P1476 | title | Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome | |
| P478 | volume | 135 |
| Q64029444 | A Bayesian Account of the Sensory-Motor Interactions Underlying Symptoms of Tourette Syndrome |
| Q92510510 | A Chinese Herbal Formulation, Xiao-Er-An-Shen Decoction, Attenuates Tourette Syndrome, Possibly by Reversing Abnormal Changes in Neurotransmitter Levels and Enhancing Antioxidant Status in Mouse Brain |
| Q34516696 | A Review and Update on Tourette Syndrome: Where Is the Field Headed? |
| Q30380379 | Abnormal neuronal activity in Tourette syndrome and its modulation using deep brain stimulation |
| Q39706145 | Animal Models of Tourette Syndrome-From Proliferation to Standardization |
| Q30395243 | Animal models of tic disorders: a translational perspective |
| Q35121068 | Cefdinir for recent-onset pediatric neuropsychiatric disorders: a pilot randomized trial |
| Q50545788 | Cerebellar neurophysiology in Gilles de la Tourette syndrome and its role as a target for therapeutic intervention. |
| Q92615787 | Clinical improvement following vitamin D3 supplementation in children with chronic tic disorders |
| Q36128281 | Common therapeutic mechanisms of pallidal deep brain stimulation for hypo- and hyperkinetic movement disorders |
| Q42075512 | Comparing GABA-dependent physiological measures of inhibition with proton magnetic resonance spectroscopy measurement of GABA using ultra-high-field MRI |
| Q48676135 | Cortical and brainstem plasticity in Tourette syndrome and obsessive-compulsive disorder |
| Q36373785 | Corticostriatal Divergent Function in Determining the Temporal and Spatial Properties of Motor Tics. |
| Q35121045 | Cytokine correlations in youth with tic disorders |
| Q28076050 | Deep Brain Stimulation for Tourette's Syndrome: The Case for Targeting the Thalamic Centromedian-Parafascicular Complex |
| Q42436987 | Deep brain stimulation reduces Tic-related neural activity via temporal locking with stimulus pulses |
| Q36328102 | Dysfunctions of the basal ganglia-cerebellar-thalamo-cortical system produce motor tics in Tourette syndrome |
| Q37724959 | Effect of "jian-pi-zhi-dong decoction" on gamma-aminobutyric Acid in a mouse model of tourette syndrome. |
| Q36931625 | Effect of Jian-Pi-Zhi-Dong Decoction on striatal glutamate and γ-aminobutyric acid levels detected using microdialysis in a rat model of Tourette syndrome |
| Q90219120 | Efficacy and safety of a GABAergic drug (Gamalate® B6): effects on behavior and cognition in young adults with borderline-to-mild intellectual developmental disabilities and ADHD |
| Q37697947 | Elucidating the nature and mechanism of tic improvement in tourette syndrome: a pilot study |
| Q47867187 | GABA and glutamate in children with Tourette syndrome: A 1H MR spectroscopy study at 7T. |
| Q27314716 | GABA and glutamate pathways are spatially and developmentally affected in the brain of Mecp2-deficient mice |
| Q27008846 | Genetic susceptibility and neurotransmitters in Tourette syndrome |
| Q43968549 | Global dysrhythmia of cerebro-basal ganglia-cerebellar networks underlies motor tics following striatal disinhibition. |
| Q30578981 | Imaging the where and when of tic generation and resting state networks in adult Tourette patients |
| Q34042170 | Increased GABA contributes to enhanced control over motor excitability in Tourette syndrome |
| Q94521606 | Individual differences in stereotypy and neuron subtype translatome with TrkB deletion |
| Q26781803 | Inhibition, Disinhibition, and the Control of Action in Tourette Syndrome |
| Q46134256 | Loss of inhibition in sensorimotor networks in focal hand dystonia |
| Q33659830 | Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives |
| Q28071336 | Molecular imaging of movement disorders |
| Q43960863 | Motor control, habits, complex motor stereotypies, and Tourette syndrome |
| Q35219542 | Motor excitability during movement preparation in Tourette syndrome |
| Q30544950 | Motor tics evoked by striatal disinhibition in the rat. |
| Q91045801 | Mutations in ASH1L confer susceptibility to Tourette syndrome |
| Q30993889 | Neuroimaging of tic genesis: Present status and future perspectives |
| Q55252475 | Olfactory functioning in adults with Tourette syndrome. |
| Q34442368 | PET Neuroimaging: Insights on Dystonia and Tourette Syndrome and Potential Applications |
| Q39070340 | Pathological glutamatergic neurotransmission in Gilles de la Tourette syndrome |
| Q37169589 | Premonitory urges are associated with decreased grey matter thickness within the insula and sensorimotor cortex in young people with Tourette syndrome |
| Q26829786 | Prenatal stress and inhibitory neuron systems: implications for neuropsychiatric disorders |
| Q39417632 | Psychiatric comorbidities in movement disorders. |
| Q26766090 | Recent Advances in Understanding and Managing Tourette Syndrome |
| Q35942500 | Reduced GABAergic inhibition and abnormal sensory symptoms in children with Tourette syndrome |
| Q103810560 | Role of Ash1l in Tourette syndrome and other neurodevelopmental disorders |
| Q27335288 | Role of the sensorimotor cortex in Tourette syndrome using multimodal imaging |
| Q50045831 | Serum levels of 25-hydroxyvitamin D in children with tic disorders |
| Q48273459 | Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study. |
| Q39348947 | The Role of Interneurons in Autism and Tourette Syndrome |
| Q52593089 | The basal ganglia and the cerebellum: nodes in an integrated network. |
| Q47560641 | Tics and Tourette syndrome - surplus of actions rather than disorder? |
| Q28067286 | Tourette Syndrome and Comorbid Neuropsychiatric Conditions |
| Q36198983 | Tourette Syndrome: Bridging the Gap between Genetics and Biology |
| Q30655945 | Tourette Syndrome: Complementary Insights from Measures of Cognitive Control, Eyeblink Rate, and Pupil Diameter |
| Q27022064 | Tourette Syndrome: Update |
| Q38249952 | Tourette syndrome and comorbid ADHD: causes and consequences. |
| Q46279291 | Tourette syndrome: a disorder of the social decision-making network |
| Q90612283 | Tourette's disorder in children and adolescents |
| Q64968646 | Tourette-Like Syndrome in a Patient with RBFOX1 Deletion. |
| Q41849040 | Treatment of Tourette syndrome |
| Q39035125 | What makes you tic? Translational approaches to study the role of stress and contextual triggers in Tourette syndrome |
Search more.